{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:10:04Z","timestamp":1784725804085,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Targeted therapies for sepsis have failed to show benefit due to high variability among subjects. We sought to demonstrate different phenotypes of septic shock based solely on clinical features and show that these relate to outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis was performed of a 1,023-subject cohort with early septic shock from the ProCESS trial. Twenty-three clinical variables at baseline were analyzed using hierarchical clustering, with consensus clustering used to identify and validate the ideal number of clusters in a derivation cohort of 642 subjects from 20 hospitals. Clusters were visualized using heatmaps over 0, 6, 24, and 72 h. Clinical outcomes were 14-day all-cause mortality and organ failure pattern. Cluster robustness was confirmed in a validation cohort of 381 subjects from 11 hospitals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five phenotypes were identified, each with unique organ failure patterns that persisted in time. By enrollment criteria, all patients had shock. The two high-risk phenotypes were characterized by distinct multi-organ failure patterns and cytokine signatures, with the highest mortality group characterized most notably by liver dysfunction and coagulopathy while the other group exhibited primarily respiratory failure, neurologic dysfunction, and renal dysfunction. The moderate risk phenotype was that of respiratory failure, while low-risk phenotypes did not have a high degree of additional organ failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Sepsis phenotypes with distinct biochemical abnormalities may be identified by clinical characteristics alone and likely provide an opportunity for early clinical actionability and prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.794423","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:14:02Z","timestamp":1652940842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Identification of Clinical Phenotypes in Septic Patients Presenting With Hypotension or Elevated Lactate"],"prefix":"10.3389","volume":"9","author":[{"given":"Zachary T.","family":"Aldewereld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Ang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Swigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipsita","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Clermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4161\/viru.26083","article-title":"Animal models of sepsis","volume":"5","author":"Fink","year":"2014","journal-title":"Virulence"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis","volume":"166","author":"Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1097\/CCM.0b013e31821e87ab","article-title":"Emergency Medicine Shock Research N. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol","volume":"39","author":"Puskarich","year":"2011","journal-title":"Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1189\/jlb.0806542","article-title":"The disconnect between animal models of sepsis and human sepsis","volume":"81","author":"Rittirsch","year":"2007","journal-title":"J Leukoc Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/SHK.0b013e31827dafa7","article-title":"Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier","volume":"39","author":"Rivers","year":"2013","journal-title":"Shock"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa063842","article-title":"Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412","volume":"355","author":"Suntharalingam","year":"2006","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 Receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit Care Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/CCM.0000000000004842","article-title":"Sepsis subclasses: a framework for development and interpretation","volume":"49","author":"DeMerle","year":"2021","journal-title":"Crit Care Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis","volume":"321","author":"Seymour","year":"2019","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","article-title":"A randomized trial of protocol-based care for early septic shock","volume":"370","author":"Yealy","year":"2014","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/SHK.0000000000001029","article-title":"Graph theoretical analysis of genome-scale data: examination of gene activation occurring in the setting of community-acquired pneumonia","volume":"50","author":"Peck Palmer","year":"2018","journal-title":"Shock"},{"key":"B15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2105-15-110","article-title":"On finding bicliques in bipartite graphs: a novel algorithm and its application to the integration of diverse biological data types","volume":"15","author":"Zhang","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5962","DOI":"10.1038\/ncomms6962","article-title":"Endothelial destabilization by angiopoietin-2 via integrin beta1 activation","volume":"6","author":"Hakanpaa","year":"2015","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1172\/JCI66549","article-title":"Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis","volume":"123","author":"Ziegler","year":"2013","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0166840","DOI":"10.1371\/journal.pone.0166840","article-title":"The Relationship between endothelial dysfunction and endothelial cell markers in peripheral arterial disease","volume":"11","author":"Igari","year":"2016","journal-title":"PLoS ONE"},{"key":"B20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.thromres.2011.10.011","article-title":"Plasma ADAMTS13, von Willebrand factor (VWF) and VWF propeptide profiles in patients with DIC and related diseases","volume":"129","author":"Habe","year":"2012","journal-title":"Thromb Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e673","DOI":"10.1097\/CCM.0000000000004968","article-title":"Determining the electronic signature of infection in electronic health record data","volume":"49","author":"Churpek","year":"2021","journal-title":"Crit Care Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00134-015-3764-7","article-title":"Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome","volume":"41","author":"Knox","year":"2015","journal-title":"Intensive Care Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13054-018-2279-3","article-title":"Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis","volume":"22","author":"Zhang","year":"2018","journal-title":"Crit Care"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jcrc.2018.06.012","article-title":"Six subphenotypes in septic shock: Latent class analysis of the PROWESS shock study","volume":"47","author":"Gardlund","year":"2018","journal-title":"J Crit Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/PCC.0000000000002105","article-title":"Eunice Kennedy Shriver National Institute of Child H, Human Development Collaborative Pediatric Critical Care Research N. A multicenter network assessment of three inflammation phenotypes in pediatric sepsis-induced multiple organ failure","volume":"20","author":"Carcillo","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1741-7015-7-34","article-title":"Identification of pediatric septic shock subclasses based on genome-wide expression profiling","volume":"7","author":"Wong","year":"2009","journal-title":"BMC Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1289","DOI":"10.1097\/CCM.0000000000002733","article-title":"Pediatric sepsis endotypes among adults with sepsis","volume":"45","author":"Wong","year":"2017","journal-title":"Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1097\/CCM.0000000000004875","article-title":"Comparison of sepsis definitions as automated criteria","volume":"49","author":"Yu","year":"2021","journal-title":"Crit Care Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fimmu.2018.00838","article-title":"Endothelial activation: the Ang\/Tie axis in sepsis","volume":"9","author":"Leligdowicz","year":"2018","journal-title":"Front Immunol"},{"key":"B31","unstructured":"2019"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat Rev Nephrol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.794423\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T06:14:06Z","timestamp":1652940846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.794423\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":32,"alternative-id":["10.3389\/fmed.2022.794423"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.794423","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"article-number":"794423"}}